This morning, Johnson & Johnson shared its 2024 fourth-quarter and full-year earnings report.
Since its founding in 1886, the company has been committed to innovation—today, more than 130,000 employees across the globe work to deliver solutions for patients around the world to help profoundly impact health for humanity.
“Johnson & Johnson delivered another year of solid results in 2024, marked by strategically important investments while advancing the pipelines of both our Innovative Medicine and MedTech businesses,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “We begin 2025 focused on bringing new treatments and innovations to patients, delivering on our near- and long-term financial targets and creating value for our shareholders.”
For more details about the company’s 2024 fourth-quarter and full-year results, and to read a message from Chairman and Chief Executive Officer Joaquin Duato, here’s an infographic highlighting key stats.
Johnson & Johnson’s 2024 Earnings
Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.
